Sibutramine N-Oxide (HCl salt) - Request Quote
Sibutramine N-Oxide (HCl salt)
| SZ CAT No: | SZ-S022013 |
| CAS No | NA |
| Mol.F. | C17H26ClNO : HCl |
| Mol.Wt. | 295.9 : 36.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sibutramine N-Oxide (HCl salt) is chemically 1-(1-(4-Chlorophenyl)cyclobutyl)-N,N,3-trimethylbutan-1-amine oxide hydrochloride. Sibutramine N-Oxide (HCl salt) is supplied with detailed characterization data compliant with regulatory guideline. Sibutramine N-Oxide (HCl salt) can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sibutramine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Sibutramine N-Oxide (HCl salt)
Purchase Sibutramine N-Oxide (HCl salt)
Sibutramine N-Oxide (HCl salt) suppliers
Sibutramine N-Oxide (HCl salt) manufacturers
Sibutramine N-Oxide (HCl salt) price
Order Sibutramine N-Oxide (HCl salt)
Enquire Sibutramine N-Oxide (HCl salt)
Sibutramine N-Oxide (HCl salt) cost
Sibutramine N-Oxide (HCl salt) Supplier
Sibutramine N-Oxide (HCl salt) Distributor
Sibutramine N-Oxide (HCl salt) for Method Validation
Sibutramine Reference Standard
Sibutramine N-Oxide (HCl salt) for ANDA Filing
Sibutramine N-Oxide (HCl salt) for Forced Degradation Studies
Sibutramine N-Oxide (HCl salt) Identification Standards
Sibutramine N-Oxide (HCl salt) for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


